The phase 2a trial showed GR-0621 met primary and secondary endpoints, demonstrating safety and efficacy over 12 weeks. Phase 2a data show oral GRI-0621 was safe and improved immune and fibrosis ...
HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...
The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine’s Center for Space Medicine, with consortium partners California Institute of Technology and Massachusetts ...
(RTTNews) - Cognition Therapeutics Inc. (CGTX), a clinical-stage biopharmaceutical company, on Monday, provided an update on a biomarker analysis from its phase II SHINE study of CT1812in ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long term survivors (>=2 years) from ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
News-Medical.Net on MSN
TGM2 as a novel biomarker for acute myocardial infarction and prognosis in acute coronary syndrome
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has been implicated in various health conditions, yet its role in acute coronary ...
To improve ovarian cancer screening, researchers led by Johns Hopkins University’s Victor E. Velculescu, MD, PhD, developed a combination liquid biopsy approach. It has three components: measurements ...
In a recent editorial published in Current Pharmaceutical Analysis (Volume 18, Issue 6, 2022), researchers Dr. Behrouz Seyfinejad and Dr. Abolghasem Jouyban highlight the importance of method ...
News-Medical.Net on MSN
New blood biomarker tracks brain injury progression after ischemic stroke
A new blood marker reflects the extent of brain injury after an ischemic stroke and can predict patient outcomes months to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results